Detailed price information for Ventyx Biosciences Inc (VTYX-Q) from The Globe and Mail including charting and trades.

BioAge LabsBIOA shares catapulted Monday on promising results for the company's cardiovascular diseases treatment, a ...

LifeSci Capital analyst Sam Slutsky maintained a Hold rating on Ventyx Biosciences yesterday and set a price target of $14.00.

French newspaper La Lettre said the Paris-based biotech – which is listed on the Nasdaq – has been on Lilly's radar after ...

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2026 to 2030 based on projected revenue and net income.

Abivax stock (EPA: ABVX) surged roughly 30% in early Paris trading Monday after French media reported that US pharmaceutical giant Eli Lilly was preparing a €15 billion ($17.5 billion) acquisition ...

The company's capacity to pursue strategic deals is underpinned by the extraordinary cash flow from its GLP‑1 franchise. With a market capitalization exceeding $1.01 trillion, Eli Lilly is riding high ...

Four recent deals fueled more angst about China’s biotech progress, while Pfizer, Bristol Myers and Sarepta all worked to ...

The biopharmaceutical sector finally regained its footing in 2025. Here are 5 issues that could determine whether the renewed ...